Daylight-PDT With MAL for AK and Photodamaged Skin

NCT02736760 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

58

Enrollment

OTHER

Sponsor class

Conditions

Actinic Keratoses
Photodamaged Skin

Interventions

DRUG: Daylight photodynamic therapy using Methylaminolevulinate (MAL)
PROCEDURE: Cryosurgery

Sponsor

University Hospital Regensburg